gabexate has been researched along with interleukin-8 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, N; Kushimoto, S; Okajima, K | 1 |
| Zimmerman, JJ | 1 |
| Biasco, G; Brandi, G; De Rosa, F; Di Girolamo, S; Di Marco, M; Guarnieri, T; Macchini, M; Papi, A; Paterini, P; Tavolari, S | 1 |
| Chang, CW; Chen, YH; Lee, MF; Lin, SJ; Wang, NM | 1 |
4 other study(ies) available for gabexate and interleukin-8
| Article | Year |
|---|---|
Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation.
Topics: Analysis of Variance; Animals; Gabexate; Interleukin-8; Leukocytes; Liver; Liver Circulation; Liver Function Tests; Male; Neutrophils; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Serine Proteinase Inhibitors; Tumor Necrosis Factor-alpha | 1999 |
What's the buzz (on protease inhibitors)...tell me what's (mechanistically) happening.
Topics: Animals; Gabexate; Humans; Interleukin-8; Liver Circulation; Neutrophils; Rats; Reperfusion Injury; Serine Proteinase Inhibitors; Tumor Necrosis Factor-alpha | 1999 |
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study.
Topics: Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Down-Regulation; Drug Evaluation, Preclinical; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gabexate; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; NF-kappa B; Pancreatic Neoplasms; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Serine Proteinase Inhibitors; Vascular Endothelial Growth Factor A | 2014 |
Serine protease inhibitor gabexate mesilate attenuates american cockroach-induced bronchial damage and inflammatory cytokine release.
Topics: Animals; Bronchi; Cells, Cultured; Chemokine CCL2; Chemokines; Cockroaches; Cytokines; Epithelial Cells; Gabexate; Humans; Interleukin-8; Mitogen-Activated Protein Kinases; Phosphorylation; Serine Proteinase Inhibitors | 2014 |